original ) (raw )Update on Screening in Prostate Cancer Based on Recent Clinical Trials
Vincenzo Gentile
Reviews on Recent Clinical Trials, 2011
View PDFchevron_right
Screening for Prostate Cancer: Opportunities and Challenges
Javier Hernandez
Surgical Oncology Clinics of North America, 2005
View PDFchevron_right
Prostate cancer screening in Primary Health Care: the current state of affairs
Raj Persad
SpringerPlus, 2015
View PDFchevron_right
Prostate Cancer, Version 2.2014
Mack Roach
Journal of the National Comprehensive Cancer Network, 2014
View PDFchevron_right
Screening and treatment of localized prostate cancer decreases mortality: First analysis of the first prospective and randomized study on prostate cancer screening
Bernard Candas
The Aging Male, 1999
View PDFchevron_right
Novel approaches to improve prostate cancer diagnosis and management in early‐stage disease
Jelle Barentsz
BJU International, 2012
View PDFchevron_right
Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors
Paul Russo
Urology, 1998
View PDFchevron_right
Development and external validation of a novel risk score to identify insignificant prostate cancer
Ashwin Narasimha Sridhar
Journal of Clinical Oncology, 2017
View PDFchevron_right
Evaluation of prostatic specific antigen and digital rectal examination as screening tests for prostate cancer
Bernard Candas
The Prostate, 2000
View PDFchevron_right
Looking Back at PCPT: Looking Forward to New Paradigms in Prostate Cancer Screening and Prevention
Javier Hernandez
European Urology, 2007
View PDFchevron_right
Identification of Clinically Significant Prostate Cancer by Prostate-Specific Antigen Screening
Bruce Malkowicz
Archives of Internal Medicine, 2004
View PDFchevron_right
Clinical Stage Evaluation at Diagnosis of Prostate Cancer at Urology-Andrology Clinic Cnhu-Hkm Cotonou
Prince Pascal
Open Journal of Urology, 2015
View PDFchevron_right
Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer
james stahl
JAMA, 2010
View PDFchevron_right
An Analysis of Patients with Clinically Localized High-Risk Prostate Carcinoma
Mack Roach
The Prostate Journal, 2000
View PDFchevron_right
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Scott Lucia
JNCI: Journal of the National Cancer Institute, 2006
View PDFchevron_right
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
Scott Lucia
Cancer Prevention Research, 2008
View PDFchevron_right
Epidemiologic determinants of clinically relevant prostate cancer
Thomas Wheeler
International Journal of Cancer, 2000
View PDFchevron_right
Focus on prostate cancer
Angelo Marzo
Cancer Cell, 2002
View PDFchevron_right
ESUR prostate MR guidelines 2012
Jelle Barentsz
European Radiology, 2012
View PDFchevron_right
Decision Making in Prostate-Specific Antigen Screening
Nancy Breen
American Journal of Preventive Medicine, 2006
View PDFchevron_right
Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality
Bernard Candas
The Journal of Clinical Endocrinology & Metabolism, 1995
View PDFchevron_right
An Overview on Prostate Pathophysiology: New Insights into Prostate Cancer Clinical Diagnosis
Taize Augusto
Pathophysiology - Altered Physiological States, 2018
View PDFchevron_right
A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale
Kim Pettersson
European Journal of Epidemiology, 2017
View PDFchevron_right
A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies
Gommert Van Koeveringe
International Urology and Nephrology, 2009
View PDFchevron_right
Editorial: Challenges in the prevention of prostate cancer
Andrea Venerando
Frontiers in Oncology, 2023
View PDFchevron_right
Diagnostic Performance of Prostate Health Index (Phi) in Predicting Prostate Cancer on Prostate Biopsy; a Single Center Study
Lazar Ilievski
Journal of Morphological Sciences, 2022
View PDFchevron_right
Active surveillance vs. radical prostatectomy in favourable-risk localised prostate cancer
Henrik Jakobsen
European Urology Supplements, 2019
View PDFchevron_right
Prostate cancer; the interface between pathology and basic scientific research
Andrew Stubbs
Seminars in Cancer Biology, 1997
View PDFchevron_right
The Performance of Prostate Specific Antigen for Predicting Prostate Cancer is Maintained After a Prior Negative Prostate Biopsy
Scott Lucia
Journal of Urology, 2008
View PDFchevron_right
Prostate Cancer Risk with Positive Family History, Normal Prostate Examination Findings, and PSA Less Than 4.0 ng/mL
Javier Hernandez
Urology, 2007
View PDFchevron_right
1664: Pathological Assessment of High Grade Tumors in the Prostate Cancer Prevention Trial (PCPT)
Scott Lucia
The Journal of Urology, 2005
View PDFchevron_right
Role of primary care in the management of prostate cancer
Raj Persad
Prescriber, 2010
View PDFchevron_right
Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen
Bernard Candas
Urology, 1996
View PDFchevron_right
Prostate cancer markers: An update (Review)
Sunjit Parmar
Biomedical Reports, 2016
View PDFchevron_right
Comparing Prostate Specific Antigen Triggers for Intervention in Men With Stable Prostate Cancer on Active Surveillance
Alexandre Mamedov
Journal of Urology, 2010
View PDFchevron_right